InspireMD director Kathryn Arnold resigns; company awards ~$140k in accelerated equity and fees

InspireMD, Inc.

Kathryn Arnold, Class III director, resigns effective Dec 31, 2025; no disagreement with company.
Compensation Committee accelerates unvested equity awards and extends option expiration by two years.
Company to pay three additional quarters of board and committee member fees.
Grant of ~$140k in common stock (75%) and options (25%) at Dec 30 closing fair market value.

item 5.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.